IL6 and atherosclerosis: Lipid markers, including Lp-PLA2 and oxylipins, elucidate lipid metabolism’s contribution to atherosclerosis, while inflammatory biomarkers like TNFα, IL-6, GDF-15, and PTX3 highlight the role of chronic inflammation in CVD progression.